Hepatology, medicine and policy

Keyphrases

Publications

volume 3, 2018

Joan N Mutyoba, Jim Aizire, Fredrick Makumbi, Lynn Atuyambe, Ponsiano Ocama, Gregory D Kirk
Correlates of hepatitis B awareness and disease-specific knowledge among pregnant women in Northern and Central Uganda: a cross-sectional study. Hepatology, medicine and policy 3 (2018)
Tibor Bakacs, Rifaat Safadi, Imre Kovesdi
Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs. Hepatology, medicine and policy 3 (2018)
Mehlika Toy, Bin Wei, Tejpal S Virdi, An Le, Huy Trinh, Jiayi Li, Jian Zhang, Ann W Hsing, Samuel K So, Mindie H Nguyen
Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California. Hepatology, medicine and policy 3 (2018)
Jean-Michel Delile, Victor de Ledinghen, Marie Jauffret-Roustide, Perrine Roux, Brigitte Reiller, Juliette Foucher, Daniel Dhumeaux
Hepatitis C virus prevention and care for drug injectors: the French approach. Hepatology, medicine and policy 3 (2018)
Jacqueline A Richmond, Jeanne Ellard, Jack Wallace, Rachel Thorpe, Peter Higgs, Margaret Hellard, Alexander Thompson
Achieving a hepatitis C cure: a qualitative exploration of the experiences and meanings of achieving a hepatitis C cure using the direct acting antivirals in Australia. Hepatology, medicine and policy 3 (2018)
Marcelo Contardo Moscoso Naveira, Komal Badal, Jagadish Dhakal, Neichu Angami Mayer, Bina Pokharel, Ruben Frank Del Prado
Seroprevalence of hepatitis B and C in Nepal: a systematic review (1973-2017). Hepatology, medicine and policy 3 (2018)
Patricia A M Kracht, J E Arends, K J van Erpecum, A Urbanus, J A Willemse, A I M Hoepelman, E A Croes
Strategies for achieving viral hepatitis C micro-elimination in the Netherlands. Hepatology, medicine and policy 3 (2018)
null null
Correction to: Hepatology, Medicine and Policy: Articles with DOIs 10.1186/s41124-016-0014-8, 10.1186/s41124-016-0013-9 and 10.1186/s41124-016-0012-x. Hepatology, medicine and policy 3 (2018)
Debra A O'Leary, Eleanor Cropp, David Isaac, Paul V Desmond, Sally Bell, Tin Nguyen, Darren Wong, Jessica Howell, Jacqui Richmond, Jenny O'Neill, Alexander J Thompson
"B in IT" - a community-based model for the management of hepatitis B patients in primary care clinics using a novel web-based clinical tool. Hepatology, medicine and policy 3 (2018)
Musomba Rachel, Castelnuovo Barbara, Claire Murphy, Charlene Komujuni, Patience Nyakato, Ponsiano Ocama, Mohammed Lamorde, Philippa Easterbrook, Rosalind Parkes Ratanshi
Uptake of hepatitis B-HIV co-infection screening and management in a resource limited setting. Hepatology, medicine and policy 3 (2018)
Aleksander Krag, Marcus Schuchmann, Hanna Sodatonou, Jeff Pilot, James Whitehouse, Simone I Strasser, Mark Hudson
Design of the Prospective Real-world Outcomes Study of hepatic encephalopathy Patients' Experience on Rifaximin-α (PROSPER): an observational study among 550 patients. Hepatology, medicine and policy 3 (2018)
N Beekmans, M Klemt-Kropp
Re-evaluation of chronic hepatitis B and hepatitis C patients lost to follow-up: results of the Northern Holland hepatitis retrieval project. Hepatology, medicine and policy 3 (2018)
Vendula Belackova, Allison M Salmon, Eberhard Schatz, Marianne Jauncey
Drug consumption rooms (DCRs) as a setting to address hepatitis C - findings from an international online survey. Hepatology, medicine and policy 3 (2018)
null null
Erratum: Publisher Correction to Hepatology, Medicine and Policy: Articles with DOIs 10.1186/s41124-017-0024-1, 10.1186/s41124-017-0025-0, 10.1186/s41124-017-0026-z and 10.1186/s41124-017-0027-y. Hepatology, medicine and policy 3 (2018)

volume 2, 2017

Tongai G Maponga, Rachel Matteau Matsha, Sébastien Morin, Andrew P Scheibe, Tracy Swan, Isabelle Andrieux-Meyer, C Wendy Spearman, Marina B Klein, Jürgen Kurt Rockstroh
Highlights from the 3rd international HIV/viral hepatitis Co-infection meeting - HIV/viral hepatitis: improving diagnosis, antiviral therapy and access. Hepatology, medicine and policy 2 (2017)
Anne Marie Carew, Niamh Murphy, Jean Long, Kate Hunter, Suzi Lyons, Cathal Walsh, Lelia Thornton
Incidence of hepatitis C among people who inject drugs in Ireland. Hepatology, medicine and policy 2 (2017)
Ludmila Maistat, Natalija Kravchenko, Amulya Reddy
Hepatitis C in Eastern Europe and Central Asia: a survey of epidemiology, treatment access and civil society activity in eleven countries. Hepatology, medicine and policy 2 (2017)
Gourdas Choudhuri, Rajesh Ojha, T S Negi, Varun Gupta, Shipra Saxena, Arundhati Choudhuri, Sanjoy Pal, Jui Choudhuri, Alok Sangam
A school-based intervention of screening a movie to increase hepatitis B vaccination levels among students in Uttar Pradesh, India: impact on knowledge, awareness, attitudes and vaccination levels. Hepatology, medicine and policy 2 (2017)

volume 1, 2016

Stine Nielsen, Martyna Gassowski, Benjamin Wenz, Norbert Bannert, Claus-Thomas Bock, Claudia Kücherer, R Stefan Ross, Viviane Bremer, Ulrich Marcus, Ruth Zimmermann, null null
Concordance between self-reported and measured HIV and hepatitis C virus infection status among people who inject drugs in Germany. Hepatology, medicine and policy 1 (2016)
Anastasios Fotiou, Eleftheria Kanavou, Argyro Antaraki, Clive Richardson, Manina Terzidou, Anna Kokkevi, null null
HCV/HIV coinfection among people who inject drugs and enter opioid substitution treatment in Greece: prevalence and correlates. Hepatology, medicine and policy 1 (2016)
Alexis Llewellyn, Mark Simmonds, Will L Irving, Ginny Brunton, Amanda J Sowden
Antiretroviral therapy and liver disease progression in HIV and hepatitis C co-infected patients: a systematic review and meta-analysis. Hepatology, medicine and policy 1 (2016)
Soo Aleman
The hurdle with remaining risk for hepatocellular carcinoma in cirrhotic patients after a hepatitis C cure. Hepatology, medicine and policy 1 (2016)
Eberhard Schatz, Katrin Schiffer, Mags Maher, Magdalena Harris, Xavier Major Roca, Mojca Maticic, Astrid Leicht
The Berlin Hepatitis C Manifesto: access to prevention, testing, treatment and care for people who use drugs. Hepatology, medicine and policy 1 (2016)
Jeffrey V Lazarus
Editor-in-Chief's welcome to Hepatology, Medicine and Policy. Hepatology, medicine and policy 1 (2016)
Ruchi Sogarwal, Varada Madge, Pratyush Bishi, Apam Woleng, Rishi Garg
Predisposing, enabling, and need factors associated with utilization of HCV testing services among PWID in two settings in India. Hepatology, medicine and policy 1 (2016)
Stephen T Barclay, Graham S Cooke, Elizabeth Holtham, Aline Gauthier, Jeremie Schwarzbard, Petar Atanasov, William L Irving, null null
A new paradigm evaluating cost per cure of HCV infection in the UK. Hepatology, medicine and policy 1 (2016)
John F Dillon, Jeffrey V Lazarus, Homie A Razavi
Urgent action to fight hepatitis C in people who inject drugs in Europe. Hepatology, medicine and policy 1 (2016)
Silvano Barbosa de Oliveira, Meritxell Sabidó, Ana Roberta Pati Pascom, Juliana Machado Gisiviez, Adele Schwartz Benzaken, Fábio Mesquita
State of viral hepatitis knowledge and testing uptake in Brazil: Findings from the National Survey of Knowledge, Attitudes and Practices (PCAP-2013). Hepatology, medicine and policy 1 (2016)
Jeffrey V Lazarus, Antons Mozalevskis, Kelly Safreed-Harmon, Irina Eramova
Strengthening hepatitis B and C surveillance in Europe: results from the two global hepatitis policy surveys (2013 and 2014). Hepatology, medicine and policy 1 (2016)
Chari Cohen, Alison A Evans, Peixin Huang, W Thomas London, Joan M Block, Gang Chen
Hepatitis B knowledge among key stakeholders in Haimen City, China: Implications for addressing chronic HBV infection. Hepatology, medicine and policy 1 (2016)
Swati Jha, Divyesh Devaliya, Susan Bergson, Shripad Desai
Hepatitis B knowledge among women of childbearing age in three slums in Mumbai: a cross-sectional survey. Hepatology, medicine and policy 1 (2016)
Chul S Hyun, William R Ventura, Soon S Kim, Soyoung Yoon, Seulgi Lee
A community- based hepatitis B linkage-to-care program: a case study on Asian Americans chronically infected with hepatitis B virus. Hepatology, medicine and policy 1 (2016)
Hai-Yang Zhou, Shuang Liu, Su-Jun Zheng, Xiao-Xia Peng, Yu Chen, Carol Duan, Qing-Fen Zheng, Zhao Wang, Zhong-Ping Duan
Coverage of different health insurance programs and medical costs associated with chronic hepatitis C infection in mainland China: a cross-sectional survey in 20 provinces. Hepatology, medicine and policy 1 (2016)
Charles Gore, Stefan Wiktor, David Goldberg, Sharon Hutchinson, Jose Antonio Oñate Moreno, Raquel Peck
Roundtable discussion: how the World Hepatitis Summit 2015 strengthened stakeholders' efforts to combat viral hepatitis. Hepatology, medicine and policy 1 (2016)
Phangisile Manciya Mtshali
Responding to HBV and HCV in China and India: thematic series introduction. Hepatology, medicine and policy 1 (2016)
David FitzSimons, Greet Hendrickx, Johannes Hallauer, Heidi Larson, Daniel Lavanchy, Ina Lodewyckx, Daniel Shouval, John Ward, Pierre Van Damme
Innovative sources for funding of viral hepatitis prevention and treatment in low- and middle-income countries: a roundtable meeting report. Hepatology, medicine and policy 1 (2016)
Judith I Tsui, Stephen C Ko, Evgeny Krupitsky, Dmitry Lioznov, Christine E Chaisson, Natalia Gnatienko, Jeffrey H Samet
Insights on the Russian HCV Care Cascade: Minimal HCV Treatment for HIV/HCV Co-infected PWID in St. Petersburg. Hepatology, medicine and policy 1 (2016)